REYON Pharmaceutical Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-29,633	4,151	3,583	7,434	5,537
Depreciation & Amortization	31,794	6,344	4,782	4,534	4,666
Loss (Gain) From Sale of Assets	1.84	39.08	-1.68	-24.41	140.92
Loss (Gain) From Sale of Investments	-935.89	-387.54	2,453	-4,262	-1,125
Loss (Gain) on Equity Investments	-1,688	4,359	960.18	1,968	-1,684
Provision & Write-off of Bad Debts	19.64	24.63	-63.38	-79.34	467.28
Other Operating Activities	-4,279	-17,529	-439.2	-1,749	1,895
Change in Accounts Receivable	2,318	3,226	1,947	-1,134	-986.61
Change in Inventory	4,061	-3,470	-5,067	-3,677	2,005
Change in Accounts Payable	-1,362	1,807	3,394	61.52	563.61
Change in Income Taxes	-	-	-342.94	-	-
Change in Other Net Operating Assets	1,160	0.96	-1,781	4,460	199.4
Operating Cash Flow	1,457	-1,436	8,645	8,729	11,685
Operating Cash Flow Growth	-	-	-0.96%	-25.29%	154.04%
Capital Expenditures	-7,916	-16,012	-28,870	-63,133	-116,978
Sale of Property, Plant & Equipment	0.82	-	1.72	42.27	8
Sale (Purchase) of Intangibles	120	488.93	-2.5	-	-18.7
Investment in Securities	-493.96	-1,081	19,979	10,566	2,076
Other Investing Activities	951.61	13	152.12	-38.93	231.1
Investing Cash Flow	-7,337	-16,591	-8,739	-52,564	-114,682
Short-Term Debt Issued	12,000	3,000	-	-	3,500
Long-Term Debt Issued	-	85,000	13,100	113,900	150,100
Total Debt Issued	12,000	88,000	13,100	113,900	153,600
Long-Term Debt Repaid	-9,637	-81,121	-2,205	-116,104	-2,475
Total Debt Repaid	-9,637	-81,121	-2,205	-116,104	-2,475
Net Debt Issued (Repaid)	2,363	6,879	10,895	-2,204	151,125
Issuance of Common Stock	-	-	-	-	10,000
Repurchase of Common Stock	-	-	-	-	-76.31
Dividends Paid	-	-2,751	-2,738	-4,563	-3,464
Other Financing Activities	-	-0	-3.83	-	-9.23
Financing Cash Flow	2,363	4,128	8,153	-6,767	157,576
Foreign Exchange Rate Adjustments	-24.58	0.21	-1.28	-89.04	-34
Miscellaneous Cash Flow Adjustments	-0	-	-0	-0	-0
Net Cash Flow	-3,542	-13,898	8,058	-50,691	54,544
Free Cash Flow	-6,459	-17,448	-20,225	-54,404	-105,293
Free Cash Flow Margin	-4.43%	-11.77%	-13.39%	-35.32%	-73.73%
Free Cash Flow Per Share	-352.23	-949.87	-1102.71	-2979.96	-5942.30
Cash Interest Paid	6,659	8,478	195.52	124.02	93.37
Cash Income Tax Paid	-191.95	1,315	950.65	1,188	-1,488
Levered Free Cash Flow	-15,601	7,306	-25,600	-61,372	-109,157
Unlevered Free Cash Flow	-7,344	8,089	-25,477	-61,296	-109,087
Change in Working Capital	6,177	1,563	-1,851	-290.36	1,782

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.